The Prevalence of Hypothyroidism among Patients With β-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies

References

• Karimi M, Zarei T, Haghpanah S, et al. Evaluation of endocrine complications in β-thalassemia intermedia (β-TI): a cross-sectional multicenter study. Endocrine. 2020;69(1):220–227.
   PubMed Web of Science ®Google Scholar
• Vichinsky E, Cohen A, Thompson AA, et al. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States. Pediatr Blood Cancer. 2018;65(7):e27067.
   PubMed Web of Science ®Google Scholar
• Yaghobi M, Miri-Moghaddam E, Majid N, et al. Complications of transfusion-dependent β-thalassemia patients in Sistan and Baluchistan, South-East of Iran. Int J Hematol Oncol Stem Cell Res. 2017;11(4):242–268.
   Google Scholar
• Bordbar M, Bozorgi H, Saki F, et al. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran. J Endocrinol Invest. 2019;42(12):1467–1476.
   PubMed Web of Science ®Google Scholar
• Bazi A, Harati H, Khosravi-Bonjar A, et al. Hypothyroidism and hypoparathyroidism in thalassemia major patients: a study in Sistan and Baluchestan Province, Iran. Int J Endocrinol Metab. 2018;16(2):e13228.
   PubMed Web of Science ®Google Scholar
• Sahin HH, Dogan I. Thyroid dysfunction in chronically transfused adults with β-thalassemia major. Ann Med Res. 2019;26(4):707–712.
   Google Scholar
• Azami M, Gheisoori A, Sayehmiri F, et al. Prevalence of hypothyroidism in patients with β thalassemia major in Iran: a systematic review and meta-analysis. Iran J Ped Hematol Oncol. 2016;21(1):104–116.
   Google Scholar
• Weidlich D, Kefalas P, Guest JF. Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom. Transfusion. 2016;56(5):1038–1045.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269.
   PubMed Web of Science ®Google Scholar
• Luchini C, Stubbs B, Solmi M, et al. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal. 2017;5(4):80–84.
   Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Singhal A, Goyal H. Thyroid dysfunction in β thalassemia major patients. Thyroid Res Pract. 2020;17(2):70–75.
   Google Scholar
• Sadullah RK, Atroshi SD, Al-Allawi NA. Complications and challenges in the management of Iraqi patients with β-thalassemia major: a single-center experience. Oman Med J. 2020;35(4):e152.
   PubMedGoogle Scholar
• Manne N, Gupta BK, Yadav SK, et al. Prevalence of hypothyroidism, delayed puberty and diabetes mellitus in patients of β-thalassemia major. Int J Med Biomed Studies. 2020;4(3):14–18.
   Google Scholar
• Khan K, Saha S, Pal PP, et al. Study on association of serum ferritin with thyroid profile and oral glucose tolerance test in thalassemia major children. J Nepal Paediatr Soc. 2020;40(1):34–40.
   Google Scholar
• Karunaratna AMDS, Ranasingha JGS, Mudiyanse RM. Endocrine complications of β-thalassemia major patients—cross-sectional study. Int J Blood Transfus Immunohematol. 2020;10:100051Z02AK2020.
   Google Scholar
• Amin SS, Jalal SD, Ali KM, et al. β-Thalassemia intermedia: a single thalassemia center experience from Northeastern Iraq. Biomed Res Int. 2020;2020:1–11.
   Web of Science ®Google Scholar
• Yassouf MY, Alquobaili F, Kabalan Y, et al. Compliance with deferoxamine therapy and thyroid dysfunction of patients with β-thalassemia major in Syria. Hemoglobin. 2019;43(3):218–221.
   PubMed Web of Science ®Google Scholar
• Tan KA, Lum SH, Yahya A, et al. Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia. Singapore Med J. 2019;60(6):303–308.
   PubMed Web of Science ®Google Scholar
• Mishra KN, Kumar A. Study of thyroid profile in β thalassemia major children of North Bihar and its correlation with serum ferritin levels. J Evol Med Dent Sci. 2019;8(24):1882–1886.
   Web of Science ®Google Scholar
• Baghersalimi A, Rad AH, Koohmanaee S, et al. The cutoff of ferritin for evaluation of hypothyroidism in patients with thalassemia. J Pediatr Hematol Oncol. 2019;41(7):515–518.
   PubMed Web of Science ®Google Scholar
• Abdulla JA, Polus RK. Assessment of thyroid function in patients with β-thalassemia major and intermedia: a comparative study. Diyala J Med. 2019;17(2):115–126.
   Google Scholar
• Yousaf HMS, Sarfraz L, Hussain ST. Prevalence of hypothyroidism in patients of β thalassemia receiving blood transfusion. J Sheikh Zayed Med Coll. 2018;9(3):1453–1455.
   Google Scholar
• Yassin MA, Soliman AT, de Sanctis V, et al. Statural growth and prevalence of endocrinopathies in relation to liver iron content (LIC) in adult patients with β thalassemia major (BTM) and sickle cell disease (SCD). Acta Biomed. 2018;89(2-S):33–40.
   Google Scholar
• Upadya SH, Rukmini MS, Sundararajan S, et al. Thyroid function in chronically transfused children with β thalassemia major: a cross-sectional hospital based study. Int J Pediatr. 2018;2018:9071213.
   PubMed Web of Science ®Google Scholar
• Kadhum SJ. The prevalence of hypothyroidism among patients with β-thalassemia major. Western Iraq. Iraqi Postgrad Med J. 2018;17(2):170–174.
   Google Scholar
• Imran A, Wani G, Singh K. Assessment of thyroid profile in children with thalassemia and its correlation with serum ferritin level. Int J Med Health Res. 2018;4(10):136–138.
   Google Scholar
• Haghpanah S, Jelodari S, Karamifar H, et al. The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in southern Iran. Acta Biomed. 2018;89(1):55–60.
   PubMedGoogle Scholar
• Eshaqh-Hosseini SK, Jafari-Koshki T, Arsang-Jang S, et al. Endocrinopathy complications and the role of serum ferritin as a marker of endocrinopathy prediction in patients with β-thalassemia major. Adv Hum Biol. 2018;8(3):169–174.
   Web of Science ®Google Scholar
• Dhouib NG, Ben Khaled M, Ouederni M, et al. Growth and endocrine function in Tunisian thalassemia major patients. Mediterr J Hematol Infect Dis. 2018;10(1):e2018031.
   PubMedGoogle Scholar
• Ayoub N. Hypothyroidism in transfusion dependent β-thalassemia. Iraqi J Cancer Med Genet. 2018;9(1):36–40.
   Google Scholar
• Shah FT. Endocrine complications in thalassaemia syndromes. Session 4: multidisciplinary care, proceedings of the 2nd MEGMA Conference on Thalassaemia & Other Haemoglobinopathies, Amman, Jordan, November 11–12 2016. Haematologica. 2017. 2016;102(s1):35–38.
   Google Scholar
• Sabir H, Khalid S, Arshad K. Hypothyroidism in children suffering from β thalasemia major. Pakistan J Med Health Sci. 2017;11(1):365–367.
   Web of Science ®Google Scholar
• Rashmi RD, Ekta D, Khagneshewar M, et al. Endocrinopathy in thalassemia major patients on chelation therapy: a study of North Indian population. J Int Med Sci Acad. 2017;30(2):89–92.
   Google Scholar
• Drema L, Singh P, Singh K, et al. Thyroid profile in multi transfused children of β thalassemia major and its correlation with serum ferritin levels. Int J Curr Res Med Sci. 2017;3(3):14–21.
   Google Scholar
• Chahkandi T, Norouziasl S, Farzad M, et al. Endocrine disorders in β-thalassemia major patients. Int J Pediatr. 2017;5(8):5531–5538.
   Web of Science ®Google Scholar
• Saleem M, Ghafoor MB, Anwar J, et al. Hypothyroidism in β thalassemia major patients at Rahim Yar Khan. J Sheikh Zayed Med Coll. 2016;7(3):1016–1019.
   Google Scholar
• Jehanzeb K, Ahmad F, Lodhi MA, et al. Assessment of status of thyroid functions in patients of β thalassemia major, reporting to OPD of Military Hospital Rawalpindi. Pakistan Armed Forces Med J. 2016;66(6):809–813.
   Google Scholar
• de Sanctis V, Elsedfy H, Soliman AT, et al. Endocrine profile of β-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center. Indian J Endocrinol Metab. 2016;20(4):451–459.
   PubMedGoogle Scholar
• Altincik A, Akin M. Prevalence of endocrinopathies in Turkish children with β-thalassemia major: a single-center study. J Pediatr Hematol Oncol. 2016;38(5):389–393.
   PubMed Web of Science ®Google Scholar
• Al-Akhras A, Badr M, El-Safy U, et al. Impact of genotype on endocrinal complications in β-thalassemia patients. Biomed Rep. 2016;4(6):728–736.
   PubMed Web of Science ®Google Scholar
• Rehman H, Masood J, Sheikh S, et al. Frequency of hypothyroidism in patients of β thalassemia major. Ann Punjab Med Coll. 2019;13(1):4–6.
   Google Scholar
• Ali GS, Jubrial AMS, Najeeb MK, et al. Comparative study of the endocrine disorders of β-thalassemia major patients and control group in Duhok Province. Sci J University Zakho. 2018;6(4):135–139.
   Google Scholar
• Dede AD, Trovas G, Chronopoulos E, et al. Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease. Osteoporos Int. 2016;27(12):3409–3425.
   PubMed Web of Science ®Google Scholar
• Betts M, Flight PA, Paramore LC, et al. Systematic literature review of the burden of disease and treatment for transfusion-dependent β-thalassemia. Clin Ther. 2020;42(2):322–337.e2.
   PubMed Web of Science ®Google Scholar
• Bonifazi F, Conte R, Baiardi P, et al. Pattern of complications and burden of disease in patients affected by β thalassemia major. Curr Med Res Opin. 2017;33(8):1525–1533.
   PubMed Web of Science ®Google Scholar
• Farhangi H, Badiei Z, Moghaddam HM, et al. Assessment of heart and liver iron overload in thalassemia major patients using T2* magnetic resonance imaging. Indian J Hematol Blood Transfus. 2017;33(2):228–234.
   PubMed Web of Science ®Google Scholar
• Perera NJ, Lau NS, Mathews S, et al. Overview of endocrinopathies associated with β-thalassaemia major. Intern Med J. 2010;40(10):689–696.
   PubMed Web of Science ®Google Scholar
• Chuncharunee S, Teawtrakul N, Siritanaratkul N, et al. Review of disease-related complications and management in adult patients with thalassemia: a multi-center study in Thailand. PLoS One. 2019;14(3):e0214148.
   PubMed Web of Science ®Google Scholar
• He L-N, Chen W, Yang Y, et al. Elevated prevalence of abnormal glucose metabolism and other endocrine disorders in patients with -thalassemia major: a meta-analysis. Biomed Res Int. 2019;2019:6573497.
   PubMed Web of Science ®Google Scholar
• Koohi F, Kazemi T, Miri-Moghaddam E. Cardiac complications and iron overload in β thalassemia major patients-a systematic review and meta-analysis. Ann Hematol. 2019;98(6):1323–1331.
   PubMed Web of Science ®Google Scholar